KPTN gene homozygous variant-related syndrome in the northeast of Brazil: A case report.
Pedro H LucenaGiulia Armani-FranceschiAna Cecília Bispo-TorresIgor Dórea BandeiraMariana F G LucenaIgor MaldonadoMarielza F VeigaDiego MiguelRita LucenaPublished in: American journal of medical genetics. Part A (2020)
Alteration of the KPTN gene, responsible for the coding of kaptin (a protein involved in actin cytoskeletal dynamics), causes a syndrome characterized by macrocephaly, neurodevelopmental delay and epileptic seizures. We report the first Brazilian case of KPTN gene variation, previously described in nine subjects from four interlinked families from an Amish community in Ohio, two Estonian siblings and a 9-year-old boy from Kansas City. We report a case of KPTN-related syndrome in a 5-year-old child which presented macrocephaly, muscular hypotonia, and global development delay. The neurological examination revealed below-expected performance in coordination and balance tests, dyspraxia, and hand-mouth synkinesia. Expressive language was characterized by phono-articulatory imprecision, abundance of phonological processes and morphosyntactic immaturity. Neuropsychological assessment revealed intellectual disability with impairment of verbal and executive functions. Exome sequencing was performed. Analysis revealed a homozygous 2-nucleotide duplication c.597_598dup p.(Ser200Ilefs*55) in the KPTN gene, which is predicted to lead to a translational frameshift and formation of a premature stop codon. The phenotypic profile is similar to the cases described in the other families. Presence of macrocephaly and delayed development indicate the possibility of KPTN gene variation. Genetic testing should be carried out at an early stage in order to reach a timely diagnosis.
Keyphrases
- intellectual disability
- copy number
- genome wide
- early stage
- working memory
- autism spectrum disorder
- genome wide identification
- case report
- squamous cell carcinoma
- small molecule
- mild cognitive impairment
- transcription factor
- genome wide analysis
- resistance training
- neoadjuvant chemotherapy
- subarachnoid hemorrhage
- high intensity
- clinical evaluation